Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hendriks

Showing results (301-310 of 344) with videos related to

Pageof 35
Sort By:
British Journal of Cancer|February 12, 2024
Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancerAnaís Sánchez-Castillo, Elien Heylen, Judith Hounjet, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?Lizza E L Hendriks, -Anita J W M Brouns, Mohammad Amini, et al.
International Journal of Cancer|June 28, 2021
Toxicity of pemetrexed during renal impairment explained-Implications for safe treatmentRené J Boosman, Thomas P C Dorlo, Nikki de Rouw, et al.
British Journal of Cancer|December 30, 2023
Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancerAnaís Sánchez-Castillo, Elien Heylen, Judith Hounjet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 24, 2023
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapyFrancesco Cortiula, Lizza E L Hendriks, Robin Wijsman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2022
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancerWillem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung CancerKathryn C Arbour, Laura Mezquita, Niamh Long, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2025
Association of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) with survival in patients with oligometastatic non-small-cell lung cancer treated with immunotherapy: a multicentre retrospective studyFrancesca Rita Ogliari, Mandy Jongbloed, Rianne D W Vaes, et al.
ACS Nano|July 21, 2025
Beyond Spectral Resolution in Nanophotonic Sensing: Picometer-Level Precision with Multispectral ReadoutM S Cano-Velázquez, S Buntinx, A L Hendriks, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2026
Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatmentValentina Bartolomeo, Mandy Jongbloed, Jarno W J Huijs, et al.
Pageof 35

Showing results (301-310 of 344) with videos related to

Sort By:
Pageof 35
British Journal of Cancer|February 12, 2024
Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancerAnaís Sánchez-Castillo, Elien Heylen, Judith Hounjet, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?Lizza E L Hendriks, -Anita J W M Brouns, Mohammad Amini, et al.
International Journal of Cancer|June 28, 2021
Toxicity of pemetrexed during renal impairment explained-Implications for safe treatmentRené J Boosman, Thomas P C Dorlo, Nikki de Rouw, et al.
British Journal of Cancer|December 30, 2023
Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancerAnaís Sánchez-Castillo, Elien Heylen, Judith Hounjet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 24, 2023
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapyFrancesco Cortiula, Lizza E L Hendriks, Robin Wijsman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2022
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancerWillem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung CancerKathryn C Arbour, Laura Mezquita, Niamh Long, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2025
Association of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) with survival in patients with oligometastatic non-small-cell lung cancer treated with immunotherapy: a multicentre retrospective studyFrancesca Rita Ogliari, Mandy Jongbloed, Rianne D W Vaes, et al.
ACS Nano|July 21, 2025
Beyond Spectral Resolution in Nanophotonic Sensing: Picometer-Level Precision with Multispectral ReadoutM S Cano-Velázquez, S Buntinx, A L Hendriks, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2026
Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatmentValentina Bartolomeo, Mandy Jongbloed, Jarno W J Huijs, et al.
Pageof 35